COVID-19, Virology and Geroscience: A Perspective

J Nutr Health Aging. 2020;24(7):685-691. doi: 10.1007/s12603-020-1416-2.

Abstract

A new coronavirus, called SARS-CoV-2, was identified in Wuhan, China, in December 2019. The SARS-CoV-2 spread very rapidly, causing a global pandemic, Coronavirus Disease 2019 (COVID-19). Older adults have higher peak of viral load and, especially those with comorbidities, had higher COVID-19-related fatality rates than younger adults. In this Perspective paper, we summarize current knowledge about SARS-CoV-2 and aging, in order to understand why older people are more affected by COVID-19. We discuss about the possibility that the so-called "immunosenescence" and "inflammaging" processes, already present in a fraction of frail older adults, could allow the immune escape of SARS-CoV-2 leading to COVID-19 serious complications. Finally, we propose to use geroscience approaches to the field of COVID-19.

Keywords: COVID-19; SARS-CoV-2; aging; coronavirus; frailty; geroscience; prevention.

Publication types

  • Review

MeSH terms

  • Aged
  • Aging* / immunology
  • Aging* / pathology
  • Betacoronavirus*
  • COVID-19
  • Coronavirus Infections / epidemiology*
  • Coronavirus Infections / virology*
  • Geriatrics*
  • Humans
  • Inflammation / immunology
  • Inflammation / pathology
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Pneumonia, Viral / virology*
  • SARS-CoV-2
  • Virology*